Last update 07 Dec 2024

Human Prothrombin Complex (Lanzhou Lansheng Blood Products)

Overview

Basic Info

Drug Type
Non-recombinant coagulation factor
Synonyms-
Target
F10 x factor IX x factor VII x thrombin
Mechanism
F10 modulators(Coagulation factor X modulators), factor IX modulators(Coagulation factor IX modulators), factor VII modulators(Coagulation factor VII modulators)
Therapeutic Areas
Congenital DisordersHemic and Lymphatic DiseasesOther Diseases
Active Indication
Hemophilia B
Inactive Indication-
Originator Organization
Lanzhou Lansheng Blood Products Co., Ltd.
Active Organization
Lanzhou Lansheng Blood Products Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CN (26 Sep 2024),
Hemophilia B
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Human Prothrombin Complex (Lanzhou Lansheng Blood Products)
CTR20202425 / CompletedPhase 3
单臂、开放性、多中心临床试验评价人凝血酶原复合物治疗血友病B的有效性和安全性
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the efficacy and safety of human prothrombin complex therapy in the treatment of hemophilia B
100 Clinical Results associated with Human Prothrombin Complex (Lanzhou Lansheng Blood Products)
Login to view more data
100 Translational Medicine associated with Human Prothrombin Complex (Lanzhou Lansheng Blood Products)
Login to view more data
100 Patents (Medical) associated with Human Prothrombin Complex (Lanzhou Lansheng Blood Products)
Login to view more data
2
Literatures (Medical) associated with Human Prothrombin Complex (Lanzhou Lansheng Blood Products)
01 Aug 2021Der UnfallchirurgQ4 · MEDICINE
Proximale osteosynthetisch versorgte Femurfrakturen: Der Versorgungszeitpunkt verzögert sich bei vorbestehender Antikoagulation
Q4 · MEDICINE
01 Nov 2011Therapeutische Umschau. Revue therapeutique
Proteine mit Einfluss auf die Blutgerinnung
100 Deals associated with Human Prothrombin Complex (Lanzhou Lansheng Blood Products)
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hemophilia B
CN
Lanzhou Lansheng Blood Products Co., Ltd.
26 Sep 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free